ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #1,148Hybrid

Transplantation and Cellular Therapy

Identifier (ISSN):2666-6375(Print)/2666-6367(Online)
•
Publisher:Elsevier
Clarivate IF (2026)
4.7↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Transplantation and Cellular Therapy

WoS Q1
24573.220233.620244.420254.72026
Annual Impact Factor Metric
Current (2026):4.7
Scopus SJR & RankScopus Q1
2.251
#1,148

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
152

152 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate11.1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
1,365articles/year
28.92% Gold OA•92.68% Original Research

Aims & Scope

Transplantation and Cellular Therapy (ISSN: 2666-6375) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier. The periodical holds a Journal Impact Factor (JIF) of 4.70, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.251 (Q1), an H-index of 152.

Topics Covered (Recognized by AI)
Medicine99.9%Biology86.1%Internal medicine83.1%Genetics79%Surgery71.1%Pathology65.6%Transplantation64.4%Immunology63.7%Cell biology61.2%Stem cell59.3%Disease47.9%Hematopoietic stem cell transplantation37.9%Oncology34.3%Chemistry29.2%Haematopoiesis24.7%Biochemistry23.7%Chemotherapy22.3%Mathematics20.9%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

HEMATOLOGY

Q1
Rank20/103
IndexSCIE
JCRSCIE2026

IMMUNOLOGY

Q2
Rank57/183
IndexSCIE
JCRSCIE2026

TRANSPLANTATION

Q1
Rank6/30
IndexSCIE
JCISCIE2026

HEMATOLOGY

Q1
Rank16/103
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q1
Rank34/183
IndexSCIE
JCISCIE2026

TRANSPLANTATION

Q1
Rank7/30
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4.7
Articles / Year1,365
Total Citations186
2025
IF4.4
Articles / Year1,230
Total Citations1,310
2024
IF3.6
Articles / Year993
Total Citations2,614
2023
IF3.2
Articles / Year965
Total Citations3,994
2022
IF—
Articles / Year1,037
Total Citations5,818

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,148Scopus Q1SCImago Profile
Scopus Coverage:2021-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
2.251

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
4.02

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,771 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,941
3-Year Documents953
Citable Documents841

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cell BiologyQ1
HematologyQ1
Immunology and AllergyQ1
Molecular MedicineQ1
TransplantationQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 11.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区HEMATOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Transplantation and Cellular Therapy (ISSN: 2666-6375) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier. The periodical holds a Journal Impact Factor (JIF) of 4.70, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 2.251 (Q1), an H-index of 152.

The journal enforces rigorous peer evaluation with an annual output of approximately 1,365 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,771 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 4670e0ea-630a-4ce7-8dec-6306c1b68660
Database Updated: 2026-10-16